B2TPD9 AF NFT

Glutamyl-tRNA reductase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeiassfhr5aj625g6jrasfkgu5g4x4epbqblj7gsy6rjtrm7ojkwmjy/metadata.json
IPFS of structure file: 
bafybeibl5qfregfzefwil4s6g2xkzpmepyokmhkrasslol5m64vo5cvi3m/AF-B2TPD9-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x46EfCa788d03A3e879DAcDb96552AB8Bbc7e20b3
First NFT owner address (bech32): 
genesis1gmhu57ydqw37s7w6ekuk254t3w78ug9ndfc7sx
Current NFT ID #166551 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
166551
Accession (UniProt):
B2TPD9
Name::
Glutamyl-tRNA reductase
Experimental Method:
Predicted structure
Sequence source:
Clostridium botulinum (strain Eklund 17B / Type B)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B2TPD9 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B2TPD9|HEM1_CLOBB Glutamyl-tRNA reductase OS=Clostridium botulinum (strain Eklund 17B / Type B) OX=935198 GN=hemA PE=3 SV=1 MIAVLGIKRNTPIEIREKLTIKVNKHDEYLDKLLKYLEGVVILATCNRTEIYFNVSSINEELLKKIFEIFNWNYSYRKYIFISEDKKACKHLFEVTCGFHSKILGEDQILGQVKTSYFKSLNAKALNLELQRLFQYAITCGKKFKSQSRLFEIPVSSASIVVNESINKDCKKFMVLGYGDVGRLTMKYLLAHNINEVYLAVRNKKIKDEIMDKRVNVIDFEEKNKYINDMDCVISCTSAPHIVIKKQDINNIGSNIIIYDLAVPRDVDDDINDIDRAQVYNIDNISHINDGNKKMRFDKMDSNKFILEKYLNEYYEWKRLRSIAPFIEELKVTSKEIYNKRITTFKNKCTDKDDVDLANRMIKSTSDYYMNRAIDIMKEETLKGSEEECLRIIKSIFMTKK